CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Pulmonary hypertension

Comorbid ConditionsDisease / conditionriskpartially modifiable
14
evidence score
PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 4.8meta-analyses: 0trials: 9genetic: 0MR bonus:

References (2)

0 meta-analyses / systematic reviews

Clinical trials (7)

NCTTitleStatusTypeInterventions
NCT05473520Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis: A Phase III Randomized Control Trial (Doxy-TB)RECRUITINGINTERVENTIONALDoxycycline, Placebo
NCT05968859Peripheral Limitations in Pulmonary Hypertension and Effects of Muscle Training - The PH Training TrialACTIVE NOT RECRUITINGINTERVENTIONALAerobic Training, Leg Training
NCT00981591A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric OxideWITHDRAWNINTERVENTIONALIloprost, Placebo
NCT00080457A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment With an Open-Label Bosentan Arm in Patients With Pulmonary Arterial Hypertension (PAH)COMPLETEDINTERVENTIONALsitaxsentan sodium
NCT07157670Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.NOT YET RECRUITINGOBSERVATIONAL
NCT00377949The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary HypertensionCOMPLETEDOBSERVATIONAL
NCT00001313Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)COMPLETEDOBSERVATIONAL

Genetic associations (0)

None linked.